BTC Health (BTC) 2020年年度报告「ASX」.pdf

1、ANNUAL REPORT ANNUAL REPORT BTC HEALTH LIMITED I ASX:BTC .au YEAR ENDING 30 JUNE 2020BTC HEALTH|ANNUAL REPORT PG 1 Contents 2 Chairmans Letter 3 Directors Report 11 Corporate Governance Statement 17 Financial Report 40 Directors Declaration 41 Auditors Independence Declaration 47 Corporate Directory

2、 42 Auditor Report Independent 44 Shareholder Information BTC HEALTH|ANNUAL REPORT PG 2 Chairmans letterI am pleased to report that BTC health has made significant progress over the last 12 months to realise its vision of becoming a leading supplier of innovative medical products in Australia and Ne

3、w Zealand.BTC healths cornerstone investment,BTC Speciality Health,has successfully completed the integration of the hospital infusion business,purchased from Admedus Australia on 31 May 2019.The business has established efficient and effective supply chain and distribution systems,comparable with m

4、ultinational healthcare companies.Most importantly,this foundation enables future healthcare investments to be fully integrated in a timely manner,yielding further benefit to our customers and incremental returns to shareholders.The coronavirus pandemic has had a material impact on the anticipated g

5、rowth for the 2019/20 financial year as Governments in Australia and New Zealand cancelled elective surgeries in March 2020.Elective surgeries across both countries have subsequently reopened,albeit on a staggered basis.It is expected that the number of elective surgeries in public and private hospi

6、tals will continue to revert to pre-coronavirus pandemic volumes during the September 2020 quarter.Sales to hospitals for the 2019/20 financial year were$5.8m,being 12%17%below our pre-coronavirus forecast.The company has exercised strong expense and working capital controls throughout the year,resu